BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15194319)

  • 1. Complications following transjugular intrahepatic portosystemic shunt: a retrospective analysis.
    Silva RF; Arroyo PC; Duca WJ; Silva AA; Reis LF; Cabral CM; Sgnolf A; Domingues RB; Barao GT; Coelho DJ; Deberaldini M; Felício HC; Silva RC
    Transplant Proc; 2004 May; 36(4):926-8. PubMed ID: 15194319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
    Haskal ZJ; Radhakrishnan J
    J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.
    Montgomery A; Ferral H; Vasan R; Postoak DW
    Cardiovasc Intervent Radiol; 2005; 28(3):307-12. PubMed ID: 15886944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
    Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
    Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunts in liver transplant recipients.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    Liver Int; 2008 Feb; 28(2):240-8. PubMed ID: 18251981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW; Sood A; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P; Saad WE; Waldman D
    J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.
    Van Ha TG; Hodge J; Funaki B; Lorenz J; Rosenblum J; Straus C; Leef J
    Cardiovasc Intervent Radiol; 2006; 29(5):785-90. PubMed ID: 16850140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt--a prospective study in 53 patients.
    Gschwantler M; Gebauer A; Vavrik J; Madani B; Rohrmoser M; Schrutka-Kölbl C; Brownstone E; Fleischer J; Tscholakoff D; Weiss W
    Z Gastroenterol; 1997 Nov; 35(11):999-1005. PubMed ID: 9429285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
    Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
    Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
    Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
    Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.